Peter J. Stengel
22Patents
6h-index
68Co-inventors
72Inventor score
Filing activity: Feb 23, 2000 → Oct 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7491794B2 | Macrocyclic compounds as inhibitors of viral replication | Human Necessities | 109 | Expired |
| US9416110B2 | Process for making hydroxylated cyclopentylpyrimidine compounds | Emerging Cross-Sectional Technologies | 9 | Active |
| US9238627B2 | Preparation of and formulation comprising a MEK inhibitor | Chemistry; Metallurgy | 8 | Active |
| US9676730B2 | Process for making hydroxylated cyclopentylpyrimidine compounds | Emerging Cross-Sectional Technologies | 8 | Active |
| US9309204B2 | Process for making hydroxylated cyclopentylpyrimidine compounds | Chemistry; Metallurgy | 7 | Active |
| US9382212B1 | Preparation of and formulation comprising a MEK inhibitor | Chemistry; Metallurgy | 7 | Active |
| US7674810B2 | 1,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymerase | Chemistry; Metallurgy | 6 | Active |
| US9790190B2 | Process for making hydroxylated cyclopentylpyrimidine compounds | Emerging Cross-Sectional Technologies | 6 | Active |
| US7479489B2 | Heterocyclic antiviral compounds | Chemistry; Metallurgy | 6 | Active |
| US8680114B2 | AKT protein kinase inhibitors | Emerging Cross-Sectional Technologies | 5 | Active |
| US9562016B2 | Preparation of and formulation comprising a MEK inhibitor | Chemistry; Metallurgy | 4 | Active |
| US9598376B2 | Preparation of and formulation comprising a MEK inhibitor | Chemistry; Metallurgy | 4 | Active |
| US6313296A | Retroviral protease inhibiting compounds | Chemistry; Metallurgy | 3 | Expired |
| US9980944B2 | Preparation of and formulation comprising a MEK inhibitor | Chemistry; Metallurgy | 2 | Active |
| US6472529B2 | Retroviral protease inhibiting compounds | Chemistry; Metallurgy | 2 | Expired |
| US10398683B2 | Preparation of and formulation comprising a MEK inhibitor | Chemistry; Metallurgy | 1 | Active |
| US12358870B2 | Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof | Chemistry; Metallurgy | 0 | Active |
| US7531534B2 | Heterocyclic antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US10729678B2 | Preparation of and formulation comprising a MEK inhibitor | Chemistry; Metallurgy | 0 | Active |
| US9790206B2 | Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof | Chemistry; Metallurgy | 0 | Active |
| US10329288B2 | Process for preparing a compound | Emerging Cross-Sectional Technologies | 0 | Active |
| US7968707B2 | Retroviral protease inhibiting compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.